FDAClass IIOctober 10, 2018

Clozapine Orally Disintegrating Tablets recall

Clozapine Orally Disintegrating Tablets, 12.5 mg, 100-count bottles, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-5416-01…

Why was Clozapine Orally Disintegrating Tablets recalled?

Failed Disintegration Specifications: Out-of-specification disintegration test result obtained during routine stability testing.

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot #: 34034024B, Exp 02/20

Product
Clozapine Orally Disintegrating Tablets, 12.5 mg, 100-count bottles, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-5416-01…
Recalling firm
Teva Pharmaceuticals USA
Quantity
313 bottles
Distribution
Distributed nationwide in the USA
Recall date
October 10, 2018
Classification
Class II
Status
Terminated
Agency
FDA (drug)
Open FDA enforcement record Latest recalls